Individual InvestorsEmployee Shareholders Institutional InvestorsPrivate Companies Accredited InvestorsSeed & Angel InvestorsAsset Managers & Hedge FundsFamily OfficesVenture Capital FirmsWealth Managers & RIAsWho We Serve Trading Data Liquidity Programs Retirement Individual InvestingForge MarketplaceFind new private company investment opportunities​Browse CompaniesInstitutional TradingForge ProTrade private companies with Forge’s institutional brokerage tool​Data solutionsForge PriceA proprietary indicative price, calculated daily, for approximately 200 pre-IPO companiesForge DataAnalyze private markets via Forge’s intuitive web application​Index solutionsForge Private Market Index​Monitor a benchmark for actively traded private companies ​Forge Accuidity Private Market Index​Invest in an institutionally-managed diversified basket of private companies (QPs only)​Forge Thematic BasketsExplore focused views into key private market themesLiquidity ProgramsRetain and reward employees with company-sponsored liquidity solutions like tender offers and customized programsSelf-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRAWhat We Do All insights Reports and highlights News and trends Private market education Tips and tutorials Forge Investment OutlookPrivate Market UpdatesIPO calendarEmerging trendsPrivate company newsUpcoming IPOsAll guidesPrivate market basicsPrivate shares transactionsValuations, pricing and market trendsSelling in the private marketFAQsGlossaryCompany page and tradesProof of ownershipBid and ask submissionsForge fund offeringsInsights About UsLeadershipPeople & CultureCareers About
Log InSign Up
Who We Serve
What We Do
Insights
About

Browse Biotech & Pharma Companies

Biotech focuses on infusing biological processes with technology to improve human, animal, and environmental health. Biotech & Pharma businesses utilize technology to work toward disease prevention, treatment and cure. These businesses also work in Agtech and fuel development. Register today to discover how Forge can help you buy and sell private shares.

Register to add companies to your watchlist and get access to bids/asks activity, last matched price and trade eligibility details.

Register
Active Market Forge Price1 Last Funding Round Trade Eligibility
Company Sector & Subsector Market Activity4 Highest Bid Lowest Ask Last Matched +/- to LFR $ Total Bids $ Total Asks # Bids # Asks Current Price 6-month 1-year Total Funding Round Date Amount Raised Post-Money Valuation3 Price Key Investors Common Preferred Fund
PlexiumHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
Affinia TherapeuticsHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$219.17MSeries C10/7/2025$40M$156.61M$1.62New Enterprise Associates, Eli Lilly, Alexandria Venture Investments, Atlas Venture, Avidity Partners, F-Prime Capital, GV, Mass General Brigham Ventures, Perceptive Advisors
Electra TherapeuticsHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$302.9MSeries C10/22/2025$184.13M$460.97M$6.77Nextech, EQT Life Sciences, Sanofi, HBM Healthcare Investments, Mubadala Capital, OrbiMed, Redmile Group, New Leaf Venture Partners, Westlake BioPartners, Cormorant Asset Management, Blue Owl Capital, RA Capital Management
Element BiosciencesHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$1.5BSeries D-17/11/2024$138.5M$1.05B$7.84Wellington Management, Samsung Electronics, Fidelity, Foresite Capital, T. Rowe Price Associates, Venrock
Nabla BioHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$107.26MSeries B5/15/2026$70.12M$476.82M$47.41Undisclosed Investors
Strand TherapeuticsHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$266.03MSeries B-28/7/2025$120M$567.33M$10.88Kinnevik, Regeneron Ventures, ICONIQ Capital, Amgen Ventures, Alderline Group, JIC Venture Growth Investments, LG Technology Ventures, Gradiant, FPV Ventures, Playground Global, Eli Lilly, ANRI, Potentum Partners
Ultima GenomicsHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
Alloy TherapeuticsHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$176.24MSeries E-14/15/2026$30M$1B$26.178VC, JIC Venture Growth Investments, Echo Capital, Mubadala Capital, Presight Capital, Thiel Capital, Founders Fund, Alexandria Venture Investments, Gaingels, Ulysses Diversified Holdings
ArteraAIHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$97.32MSeries Seed-32/1/2024$82.82M$408.31M$7.95Coatue, Johnson & Johnson Innovation, Koch Disruptive Technologies, Walden Catalyst, TIME Ventures, Breyer Capital, The Factory, Marc Benioff, Jim Breyer, Lip-Bu Tan, Chris Re, Andy Jacques, Amarjit Gill, Jeff Dean, Steve Blank, Dennis Wong, Clarence So, Michael Driscoll, Prosperity7 Ventures, EDBI, Wilson Sonsini Goodrich & Rosati, Trium Ventures, Navin Chaddha, Rajiv Khemani, Andrew Tan, Elliott Tan
Circle PharmaHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$348.74MSeries E-18/6/2026$92.5M$269.89M$0.27Undisclosed Investors
GametoHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$117MSeries C8/12/2025$44M$234.3M$7.31Overwater Ventures, Insight Partners, RA Capital, Two Sigma Ventures, BOLD Capital Partners, Future Ventures, Ingeborg Investments, Arcadia Investment Partners, PAGS Group, Pontiva Healthcare Partners, Portfolia
Genesis Molecular AIHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$340.28MSeries B-35/20/2026$40M$806.79M$9.33Incyte
SetPoint MedicalHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$303.01MSeries D8/11/2025$115M$471.62M$1.51Elevage Medical Technologies, Ally Bridge Group, Northwell Health, SPRIG Equity, Norwest Venture Partners, New Enterprise Associates, Viking Global Investors, Action Potential Venture Capital, Abbott, Boston Scientific, Euclidean Capital, Richard King Mellon Foundation, Morgenthaler Ventures, ShangBay Capital, Ascendum Capital, Catalio Capital Management, Gilmartin Capital, Midas Capital
Tessera TherapeuticsHealthcare
Biotech & Pharma
Low$xx.xx$xx.xx$xx.xxxx%--------Not available----$587.85MSeries D12/1/2025$200M$668.33M$5.18Bill & Melinda Gates Foundation, Regeneron
ValoHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$406.25MSeries B3/9/2021$310M$919.92M$5.88PSP Investments, Flagship Pioneering, Invus Public Equities, HBM Healthcare Investments, Atinum Investment, Mirae Asset Capital, Koch Disruptive Technologies
ANDEHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
Ankyra TherapeuticsHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
Bionaut LabsHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
EmbarkHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$94.55MSeries B7/26/2021$75M$759.47M$16.96SoftBank, F-Prime Capital, SV Angel, Slow Ventures, Freestyle Capital, Third Kind Venture Capital
Epic SciencesHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$606.66MSeries A-312/29/2023$20.9M$94.14M$3.00Undisclosed Investors
Ginkgo BioworksHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$785.53MSeries E5/28/2020$360M$4.89B$150.19T. Rowe Price, Allen & Company, Baillie Gifford, Cascade Investment, General Atlantic, Reshape Holdings, Viking Global Investors, Illumina
Kriya TherapeuticsHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$940.5MSeries D9/10/2025$320.82M$1.67B$10.34Patient Square Capital, Premji Invest, Peter Thiel, Narya Capital, The T1D Fund
Medeor TherapeuticsHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
Obsidian TherapeuticsHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$329.03MSeries C4/3/2024$160.5M$480.83M$1.90Wellington Management, Foresite Capital, Janus Henderson Investors, Novo Holdings, Paradigm BioCapital, RTW Investments, T. Rowe Price Associates, Woodline Partners, Atlas Venture, Blue Owl Capital, Bristol Myers Squibb, Deep Track Capital, Logos Capital, RA Capital Management, TCG Crossover Management, Samsara, Surveyor Capital

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

  1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.

  2. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.

  3. Post-Money Valuation (valuation) represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).

  4. Market activity indicates the level of activity for a company based on recent IOIs, secondary transactions, and pending transactions.

Sector and subsector descriptions focus primarily on the types of companies within the respective sectors and subsectors that are typically available through Forge Markets. Any sector or subsector as a whole may include companies that participate in business lines in other sectors or subsectors. Companies are classified into sectors and subsectors according to the problem(s) they seek to solve rather than the method by which the solution is delivered.